23 "Lung Disease" clinical trials found.

• 

  Measurement of Pulmonary Inflammation Using F-NOS Positron Emission Tomography (PET/CT) in E-cigarette Users

  This is a 2 visit study to occur over 1 – 2 months. This study examines and compares inflammation between e-cigarette ...

  Jacob Dubroff See if you qualify

• 

  An extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension

  This is a Phase 3a, extended access program to assess long-term safety of bardoxolone methyl in patients with pulmonary hypertension ...

  Harold Palevsky Md

• 

  Intraoperative molecular imaging of pulmonary nodules by BY SGM-101

  Sunil Singhal Md

• 

  Human Respiratory Virome in Health and Lung Disease-Lung Bronchoscopy Cohort

  Humans live in a closely interdependent relationship with microbes that inhabit the human body (the human microbiome), but the viruses ...

  Ronald Collman Md

• 

  A PHASE III RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF AEROVANC FOR THE TREATMENT OF PERSISTANT METHICILLIN-RESISTANT Staphylococcus aureus LUNG INFECTION IN ...

  TBD

  Daniel J Dorgan

• 

  Intratumoral Gene Mediated Cytotoxic Immunotherapy (GMCI) For Resectable Non-Small Cell Lung Cancer

  Surgery is the best treatment for patients with Stage I or II lung cancer; however, nearly 60% of patients have ...

  Sunil Singhal Md Charuhas Deshpande Lydia Frenzel Sulyok

• A Phase 2 Multicenter, Double-blind, Randomized, Placebo-Controlled Trial to Evaluate Oral Ifetroban in Subjects with Symptomatic Aspirin Exacerbated Respiratory Disease ...

  The primary purpose of this study is to determine the therapeutic effectiveness of Ifetroban to improve sinus and nasal symptoms ...

  Laurel Doghramji

• UPCC 09517: Phase II study of Pembrolizumab and Itacitinib (INCB039110) for First Line Treatment of Metastatic Non-Small Cell Lung Cancer ...

  The main purpose of this study is to examine the efficacy of adding itacitinib (also known as INCB039110) to pembrolizumab ...

  Joshua Bauml

• Open-Labeled Trial Of Zepatier For Treatment Of Hepatitis C-Negative Patients Who Receive Lung Transplants From Hepatitis C-Positive Donors

  There has only been a modest increase in the number of lung transplants each year, increasing from a yearly average ...

  David Goldberg

• UPCC 06518: A Phase 2 Precision Oncology Study of Biomarker-Directed Pembrolizumab-Based Combination Therapy for Advanced Non-Small Cell Lung Cancer

  To evaluate the clinical activity (as assessed by objective response rate [ORR]) pembrolizumab (MK-3475) in combination with MK-4280 or lenvatinib ...

  Charu Aggarwal